Pet imaging in preclinical anti-aβ drug development

HIGHLIGHTS

  • who: Stina Syvu00e4nen from the Department of Public Health and Caring Sciences, Uppsala University, Dag Hammarskju00f6ldsvu00e4g, Uppsala, Sweden have published the article: PET Imaging in Preclinical Anti-Au03b2 Drug Development, in the Journal: (JOURNAL)
  • what: This may be one of the most relevant applications of PET in animal models, as the main objective of such studies is to verify reduced Au03b2 levels in treated mice compared to non-treated, and at the same time, other aspects related to age and transgene effects may be less crucial.

SUMMARY

    Department of Public Health . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?